Apogee Therapeutics, Inc.

The momentum for this stock is not very good. Apogee Therapeutics, Inc. is not a good growth stock. Apogee Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Apogee Therapeutics, Inc..

News

Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit

Globe Newswire SAN FRANCISCO and WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for...\n more…

TD Asset Management Inc Reduces Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Zolmax TD Asset Management Inc trimmed its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 35.9% in the 2nd quarter, according to the company in its most recent filing with the Securities...\n more…

Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer

Globe Newswire SAN FRANCISCO and WALTHAM, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for...\n more…

Insider Selling: Apogee Therapeutics, Inc. (NASDAQ:APGE) Insider Sells 6,665 Shares of Stock

Ticker Report Apogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 6,665 shares of the business's stock in a transaction that occurred on Wednesday, September 4th. The stock was...\n more…

Have Insiders Sold Apogee Therapeutics Shares Recently?

Simply Wall St We'd be surprised if Apogee Therapeutics, Inc. ( NASDAQ:APGE ) shareholders haven't noticed that the Chief Financial...\n more…